Found: 132
Select item for more details and to access through your institution.
Comparative evaluation of the new GRPR‐antagonist <sup>111</sup>In‐SB9 and <sup>111</sup>In‐AMBA in prostate cancer models: Implications of in vivo stability.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 646, doi. 10.1002/jlcr.3733
- By:
- Publication type:
- Article
Toward Stability Enhancement of NTS 1 R-Targeted Radioligands: Structural Interventions on [ 99m Tc]Tc-DT1.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 8, p. 2092, doi. 10.3390/pharmaceutics15082092
- By:
- Publication type:
- Article
Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK 2 R Cancer Theranostic Agents: A Preclinical Study.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 3, p. 666, doi. 10.3390/pharmaceutics14030666
- By:
- Publication type:
- Article
One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [ 99m Tc]Tc-DB4 and [ 111 In]In-SG4 in Mice Treated with Entresto.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 12, p. 1145, doi. 10.3390/pharmaceutics12121145
- By:
- Publication type:
- Article
Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 6, p. 528, doi. 10.3390/pharmaceutics12060528
- By:
- Publication type:
- Article
Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses.
- Published in:
- Pharmaceuticals (14248247), 2019, v. 12, n. 1, p. 42, doi. 10.3390/ph12010042
- By:
- Publication type:
- Article
Refractory immune-mediated and haematological diseases: candidates for peptide receptor radiotherapy?
- Published in:
- European Journal of Endocrinology, 2000, p. S53, doi. 10.1530/eje.0.143s053
- By:
- Publication type:
- Article
Changes in renal tri-iodothyronine and thyroxine handling during fasting.
- Published in:
- European Journal of Endocrinology, 2000, v. 142, n. 2, p. 125, doi. 10.1530/eje.0.1420125
- By:
- Publication type:
- Article
Optimizing the Profile of [ 99m Tc]Tc–NT(7–13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 7926, doi. 10.3390/ijms21217926
- By:
- Publication type:
- Article
Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy.
- Published in:
- Neuroendocrinology, 2013, v. 97, n. 1, p. 74, doi. 10.1159/000335018
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs.
- Published in:
- Neuroendocrinology, 2009, v. 90, n. 2, p. 220, doi. 10.1159/000225951
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with In-Pentetreotide.
- Published in:
- Neuroendocrinology, 2009, v. 90, n. 2, p. 184, doi. 10.1159/000225946
- By:
- Publication type:
- Article
Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 5, p. 767, doi. 10.1002/(SICI)1097-0215(19990531)81:5<767::AID-IJC17>3.0.CO;2-T
- By:
- Publication type:
- Article
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 4, p. 658, doi. 10.1002/(SICI)1097-0215(19990517)81:4<658::AID-IJC24>3.0.CO;2-P
- By:
- Publication type:
- Article
Pre-clinical comparison of [DTPA.
- Published in:
- International Journal of Cancer, 1998, v. 75, n. 3, p. 406, doi. 10.1002/(SICI)1097-0215(19980130)75:3<406::AID-IJC14>3.0.CO;2-6
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours.
- Published in:
- Acta Oncologica, 2007, v. 46, n. 6, p. 723, doi. 10.1080/02841860701441848
- By:
- Publication type:
- Article
Validation of Somatostatin Receptor Scintigraphy in the Localization of Neuroendocrine Tumors.
- Published in:
- Acta Oncologica, 1993, v. 32, n. 2, p. 167, doi. 10.3109/02841869309083907
- By:
- Publication type:
- Article
The SNM Practice Guideline for Somatostatin Receptor Scintigraphy 2.0.
- Published in:
- Journal of Nuclear Medicine Technology, 2011, v. 39, n. 4, p. 317, doi. 10.2967/jnmt.111.098277
- By:
- Publication type:
- Article
Bone Mineral Density, Growth, and Thyroid Function in Long-Term Survivors of Pediatric Hodgkin’s Lymphoma Treated with Chemotherapy Only.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 6, p. 1904, doi. 10.1210/jc.2008-0622
- By:
- Publication type:
- Article
Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 2, p. 506, doi. 10.1210/jcem.87.2.8202
- By:
- Publication type:
- Article
[<sup>123</sup>I]Metaiodobenzylguanidine and [<sup>111</sup>In]Octreotide Uptake in Benign and Malignant Pheochromocytomas.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 2, p. 685, doi. 10.1210/jc.86.2.685
- By:
- Publication type:
- Article
Bone Mineral Density and Body Composition before and during Treatment with Gonadotropin-Releasing Hormone Agonist in Children with Central Precocious and Early Puberty.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1998, v. 83, n. 2, p. 370, doi. 10.1210/jcem.83.2.4573
- By:
- Publication type:
- Article
Chromogranin A as Serum Marker for Neuroendocrine Neoplasia: Comparison with Neuron-Specific Enolase and the α-Subunit of Glycoprotein Hormones.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1997, v. 82, n. 8, p. 2622, doi. 10.1210/jc.82.8.2622
- By:
- Publication type:
- Article
Changes in Bone Mineral Density, Body Composition, and Lipid Metabolism during Growth Hormone (GH) Treatment in Children with GH Deficiency.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1997, v. 82, n. 8, p. 2423, doi. 10.1210/jc.82.8.2423
- By:
- Publication type:
- Article
Bone Mineral Density in Children and Adolescents: Relation to Puberty, Calcium Intake, and Physical Activity.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1997, v. 82, n. 1, p. 57, doi. 10.1210/jcem.82.1.3665
- By:
- Publication type:
- Article
High Serum Levels of the Thyrotropin-Releasing Hormone-Like Peptide Pyroglutamyl-Glutamyl-Prolineamide in Patients with Carcinoid Tumors.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1996, v. 81, n. 8, p. 2816, doi. 10.1210/jc.81.8.2816
- By:
- Publication type:
- Article
Uptake and Metabolism of 3,5,3’-Triiodothyronine and 3,3’,5’-Triiodothyronine by Human Liver-Derived Cells: HepG2 Cells as a Model for Thyroid Hormone Handling by Human Liver.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1996, v. 81, n. 1, p. 244, doi. 10.1210/jc.81.1.244
- By:
- Publication type:
- Article
EURO-COLLINS SOLUTION VERSUS UW-SOLUTION FOR LONG-TERM LIVER PRESERVATION IN THE ISOLATED RAT-LIVER PERFUSION MODEL.
- Published in:
- HPB Surgery, 1991, v. 4, n. 4, p. 313, doi. 10.1155/1991/10965
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1014, n. 1, p. 234, doi. 10.1196/annals.1294.026
- By:
- Publication type:
- Article
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 3, p. 1, doi. 10.1111/jne.13040
- By:
- Publication type:
- Article
Transport of thyroxine into cultured hepatocytes: effects of mild non-thyroidal illness and calorie restriction in obese subjects.
- Published in:
- Clinical Endocrinology, 1994, v. 40, n. 1, p. 79, doi. 10.1111/j.1365-2265.1994.tb02447.x
- By:
- Publication type:
- Article
Endocrine aspects of the diagnosis and treatment of primary brain tumours.
- Published in:
- Clinical Endocrinology, 1992, v. 37, n. 1, p. 1, doi. 10.1111/j.1365-2265.1992.tb02276.x
- By:
- Publication type:
- Article
The relation between 25-hydroxyvitamin D with peak bone mineral density and body composition in healthy young adults.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 2011, v. 24, n. 5/6, p. 355, doi. 10.1515/jpem.2011.052
- By:
- Publication type:
- Article
The relation between 25-hydroxyvitamin D with peak bone mineral density and body composition in healthy young adults.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 2011, v. 24, n. 5/6, p. 355, doi. 10.1515/JPEM.2011.052
- By:
- Publication type:
- Article
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: Y or Y imaging?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, p. 57, doi. 10.1007/s00259-011-1771-7
- By:
- Publication type:
- Article
Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 5, p. 1018, doi. 10.1007/s00259-009-1282-y
- By:
- Publication type:
- Article
Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 8, p. 1265, doi. 10.1007/s00259-009-1098-9
- By:
- Publication type:
- Article
Bone marrow dosimetry in peptide receptor radionuclide therapy with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 7, p. 1138, doi. 10.1007/s00259-009-1072-6
- By:
- Publication type:
- Article
Peptide receptor radionuclide therapy with <sup>177</sup>Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 8, p. 1219, doi. 10.1007/s00259-006-0355-4
- By:
- Publication type:
- Article
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 5, p. 763, doi. 10.1007/s00259-006-0291-3
- By:
- Publication type:
- Article
Long-term toxicity of [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate in rats.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 2, p. 219, doi. 10.1007/s00259-006-0232-1
- By:
- Publication type:
- Article
[<sup>99m</sup>Tc]Demotate 2 in the detection of sst<sub>2</sub>-positive tumours: a preclinical comparison with [<sup>111</sup>In]DOTA-tate.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 7, p. 831, doi. 10.1007/s00259-006-0068-8
- By:
- Publication type:
- Article
Localisation and mechanism of renal retention of radiolabelled somatostatin analogues.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 10, p. 1136, doi. 10.1007/s00259-005-1793-0
- By:
- Publication type:
- Article
Optimising conditions for radiolabelling of DOTA-peptides with [sup 90] Y, [sup 111] In and [sup 177] Lu at high specific activities.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 6, p. 917, doi. 10.1007/s00259-003-1142-0
- By:
- Publication type:
- Article
[sup 86] Y-DOTA[sup 0] -d-Phe[sup 1] -Tyr[sup 3] -octreotide (SMT487)—a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 4, p. 510, doi. 10.1007/s00259-003-1117-1
- By:
- Publication type:
- Article
Radiolabelled peptides for tumour therapy: current status and future directions: Plenary lecture at the EANM 2002.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 3, p. 463, doi. 10.1007/s00259-002-1107-8
- By:
- Publication type:
- Article
[sup 99m] Tc-tetrofosmin or [sup 99m] Tc-sestamibi for double-phase parathyroid scintigraphy?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 2, p. 193, doi. 10.1007/s00259-002-1030-z
- By:
- Publication type:
- Article
The addition of DTPA to [[sup 177] Lu-DOTA[sup 0] ,Tyr[sup 3] ]octreotate prior to administration reduces rat skeleton uptake of radioactivity.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 2, p. 312, doi. 10.1007/s00259-002-1054-4
- By:
- Publication type:
- Article
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 1, p. 9, doi. 10.1007/s00259-002-0982-3
- By:
- Publication type:
- Article
Sensitivity of [sup 123] I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2002, v. 29, n. 6, p. 768, doi. 10.1007/s00259-002-0781-x
- By:
- Publication type:
- Article